T2DM is mainly characterized by a progressive decline in insulin action (insulin resistance), followed by the inability of beta cells to compensate for insulin resistance (pancreatic beta cell dysfunction) (Lebovitz and Banerji, 2004). The gene discussed is INS; the disease is type 2 diabetes mellitus.